• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Waystar Reports Second Quarter 2024 Results

    8/7/24 4:05:00 PM ET
    $WAY
    EDP Services
    Technology
    Get the next $WAY alert in real time by email

    Revenue growth of 20% year-over-year

    Net loss of $27.7 million and non-GAAP net income of $5.0 million

    Net loss margin of (11.8)%; Adjusted EBITDA margin of 40%

    LEHI, Utah and LOUISVILLE, Ky., Aug. 7, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the three-month period ended June 30, 2024.

    "Waystar delivered strong performance across all key metrics in Q2," said Matt Hawkins, Chief Executive Officer of Waystar. "We have solid momentum as clients utilize the cloud-based Waystar software platform, which we have purpose-built to drive client return on investment and a differentiated, modern user experience."

    Hawkins continued, "There is meaningful opportunity ahead of us, as the demand for an innovative healthcare software payment platform has never been greater. As a result, Waystar is poised to continue to deliver an attractive combination of revenue growth at scale and compelling adjusted EBITDA margins."

    Second Quarter 2024 Financial Highlights

    • Revenue of $234.5 million, up 20% year-over-year
    • Net loss of $27.7 million, GAAP net income per share of $(0.21), and net loss margin of (11.8)%
    • Non-GAAP net income of $5.0 million and non-GAAP net income per share of $0.04
    • Adjusted EBITDA of $93.9 million and Adjusted EBITDA margin of 40%
    • Cash flow from operations of $15.5 million and Unlevered Free Cash Flow of $50.3 million

    Key Metrics

    • 1,117 clients contributed over $100,000 in LTM revenue, up 9% year-over-year
    • A net revenue retention rate (NRR) of 108%

    Financial Outlook

    As of August 7, 2024, Waystar provides the following guidance for its full fiscal year 2024.1

    • Total revenue is expected to be between $902 million and $918 million
    • Adjusted EBITDA is expected to be between $360 million and $368 million
    • Non-GAAP net income is expected to be between $36 million and $42 million
    • Diluted non-GAAP net income per share is expected to be between $0.23 and $0.27

    Webcast Information

    Waystar's financial results will be discussed on a conference call scheduled at 4:30 p.m. Eastern Time today, August 7, 2024. A live audio conference call will be available on Waystar's website at https://investors.waystar.com/news-events/events. The webcast will be archived on the site for those unable to listen in real-time. This earnings release and the related Current Report on Form 8-K filed August 7, 2024 can be accessed on the Investor Relations page of the company's website. We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investor Relations section of our website. Accordingly, investors should monitor this portion of our website, in addition to following our press releases, U.S. Securities and Exchange Commission ("SEC") filings, and public conference calls and webcasts.

    Non-GAAP Financial Measures

    To supplement the consolidated financial statements prepared and presented in accordance with U.S. generally accepted accounting principles ("GAAP"), this press release contains certain non-GAAP financial measures as defined below. We present non-GAAP financial measures as supplemental measures of financial performance that are not required by, or presented in accordance with, GAAP. We believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. Management uses Adjusted EBITDA and Adjusted EBITDA margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation, and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone provide.

    Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per share and unlevered free cash flow are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) or net income (loss) margin as measures of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management's discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company. A reconciliation is provided below for our non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.

    The following non-GAAP financial measures and key performance metrics are defined below:

    Adjusted EBITDA and Adjusted EBITDA Margin

    We define Adjusted EBITDA as net loss before interest expense, net income tax benefit, depreciation and amortization, and as further adjusted for stock-based compensation expense, acquisition and integration costs, asset and lease impairments, costs related to amended debt agreements, and IPO-related costs. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of revenue.

    Non-GAAP Net Income and Non-GAAP Net Income Per Share

    We define non-GAAP net income as GAAP net income excluding the impact of stock-based compensation, acquisition and integration costs, asset and lease impairments, IPO-related costs, and costs related to amended debt agreements. The tax effects of the adjustments are calculated using a management-estimated annual effective non-GAAP tax rate of 21%.

    We define non-GAAP net income per share as non-GAAP net income (loss) divided by weighted-average shares used to compute net loss per share.

    Unlevered Free Cash Flow

    We define unlevered free cash flow as cash from operations plus cash interest expense less capital expenses.

    Net Debt

    We define net debt as the sum of the current portion of long-term debt, long-term debt, and accounts receivable securitization less cash and equivalents.

    Adjusted Net Leverage Ratio

    We define adjusted net leverage ratio as net debt divided by adjusted EBITDA over the preceding twelve months.

    Key Performance Metrics

    Net Revenue Retention Rate

    Our Net Revenue Retention Rate compares twelve months of client invoices for our solutions at two period end dates. To calculate our Net Revenue Retention Rate, we first accumulate the total amount invoiced during the twelve months ending with the prior period-end or Prior Period Invoices. We then calculate the total amount invoiced to those same clients for the twelve months ending with the current period-end, or Current Period Invoices. Current Period Invoices are inclusive of upsell, downsell, pricing changes, clients that cancel or chose not to renew, and discontinued solutions with continuing clients. The Net Revenue Retention Rate is then calculated by dividing the Current Period Invoices by the Prior Period Invoices. Our total invoices included in the analysis are greater than 98% of reported revenue. We use Net Revenue Retention Rate to evaluate our ongoing operations and for internal planning and forecasting purposes. Acquired businesses are included in the last-twelve-month Net Revenue Retention Rate in the ninth quarter after acquisition, which is the earliest point that comparable post-acquisition invoices are available for both the current and prior twelve-month period.

    Customer Count with >$100,000 of Revenue

    We regularly monitor and review our count of clients who generate more than $100,000 of revenue.

    Our count of clients who generate more than $100,000 of revenue is based on an accumulation of the amounts invoiced to clients over the preceding twelve months. The invoices for acquired clients are included starting in the first full calendar quarter after the date of acquisition.

    Forward-Looking Statements

    This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar's expectations relating to future operating results and financial position, including full year 2024, and future periods; anticipated future expenses and investments; our industry, business strategy, goals, and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity, and capital resources and other financial and operating information. Forward-looking statements include all statements that are not historical facts. These statements may include words such as "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," "outlook," the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including the discussion of outlook for full fiscal year 2024.

    The forward-looking statements contained in this press release are based on management's current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients' timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes, or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients' and their vendors' networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform; the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; our use of "open source" software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; healthcare laws and data privacy and security laws and regulations governing our processing of personal information; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; consumer protection laws and regulations; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income; losses due to asset impairment charges; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of "Risk Factors" in the Company's prospectus filed with the Securities and Exchange Commission (the "SEC") on June 7, 2024 and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

    Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

    About Waystar

    Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 18 of 22 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.







    1 We have not reconciled the forward-looking Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per share guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

     

    Waystar

    Condensed Consolidated Statements of Operations

    (in thousands, except for share and per share data)

    (unaudited)







    Three months ended June 30, 



    Six months ended June 30, 





    2024



    2023



    2024



    2023

    Revenue



    $

    234,543



    $

    195,969



    $

    459,335



    $

    387,052

    Operating expenses

























    Cost of revenue (exclusive of depreciation and

         amortization expenses)





    80,451





    60,500





    155,643





    119,656

    Sales and marketing





    45,715





    31,413





    79,495





    61,377

    General and administrative





    39,955





    14,478





    66,090





    29,159

    Research and development





    15,901





    8,249





    26,221





    16,575

    Depreciation and amortization





    44,276





    44,140





    88,450





    88,106

        Total operating expenses





    226,298





    158,780





    415,899





    314,873

    Income from operations





    8,245





    37,189





    43,436





    72,179

    Other expense

























    Interest expense





    (49,195)





    (49,145)





    (105,007)





    (96,291)

    Related party interest expense





    (1,346)





    (2,001)





    (2,718)





    (4,355)

    Loss before income taxes





    (42,296)





    (13,957)





    (64,289)





    (28,467)

    Income tax benefit





    (14,611)





    (3,147)





    (20,672)





    (7,034)

    Net loss



    $

    (27,685)



    $

    (10,810)



    $

    (43,617)



    $

    (21,433)

    Net Income per share:

























    Basic



    $

    (0.21)



    $

    (0.09)



    $

    (0.34)



    $

    (0.18)

    Diluted



    $

    (0.21)



    $

    (0.09)



    $

    (0.34)



    $

    (0.18)

    Weighted-average shares outstanding:

























    Basic





    133,527,766





    121,676,273





    127,601,532





    121,674,361

    Diluted





    133,527,766





    121,676,273





    127,601,532





    121,674,361

     

    Waystar

    Condensed Consolidated Balance Sheets

    (in thousands, except for share and per share data)

    (unaudited)







    June 30, 2024



    December 31, 2023





    (Unaudited)





    Assets













    Current assets













    Cash and cash equivalents



    $

    68,375



    $

    35,580

    Restricted cash





    12,083





    9,848

    Accounts receivable, net of allowance of $5,204 at June 30, 2024 and

         $5,335 at December 31, 2023





    147,966





    126,089

    Income tax receivable





    11,181





    6,811

    Prepaid expenses





    14,758





    13,296

    Other current assets





    16,389





    30,426

      Total current assets





    270,752





    222,050

    Property, plant and equipment, net





    63,035





    61,259

    Operating lease right-of-use assets, net





    9,579





    10,353

    Intangible assets, net





    1,108,776





    1,186,936

    Goodwill





    3,030,013





    3,030,013

    Deferred costs





    77,177





    65,811

    Other long-term assets





    7,549





    6,552

      Total assets



    $

    4,566,881



    $

    4,582,974

    Liabilities and stockholders' equity













    Current liabilities













    Accounts payable



    $

    50,747



    $

    45,484

    Accrued compensation





    23,032





    23,286

    Aggregated funds payable





    11,987





    9,659

    Other accrued expenses





    11,298





    10,923

    Deferred revenue





    10,320





    10,935

    Current portion of long-term debt





    12,577





    17,454

    Related party current portion of long-term debt





    332





    529

    Current portion of operating lease liabilities





    4,711





    4,398

    Current portion of finance lease liabilities





    862





    821

      Total current liabilities





    125,866





    123,489

    Long-term liabilities













    Deferred tax liability





    130,594





    174,480

    Long-term debt, net, less current portion





    1,301,208





    2,134,920

    Related party long-term debt, net, less current portion





    32,882





    64,758

    Operating lease liabilities, net of current portion





    12,327





    14,278

    Finance lease liabilities, net of current portion





    11,750





    12,194

    Deferred revenue–LT





    5,878





    6,173

    Other long-term liabilities





    278





    2,750

      Total liabilities





    1,620,783





    2,533,042

    Commitments and contingencies (Note 18)













    Stockholders' equity













    Preferred stock $0.01 par value - 100,000,000 and zero shares authorized

         as of June 30, 2024 and December 31, 2023, respectively; zero shares

         issued or outstanding as of June 30, 2024 and December 31, 2023,

         respectively





    —





    —

    Common stock $0.01 par value - 2,500,000,000 and 227,000,000 shares

         authorized at June 30, 2024 and December 31, 2023, respectively;

         166,659,634 and 121,679,902 shares issued and outstanding at June 30,

         2024 and December 31, 2023, respectively





    1,667





    1,217

    Additional paid-in capital





    3,178,697





    2,234,688

    Accumulated other comprehensive income (loss)





    11,126





    15,802

    Accumulated deficit





    (245,392)





    (201,775)

    Total stockholders' equity





    2,946,098





    2,049,932

    Total liabilities and stockholders' equity



    $

    4,566,881



    $

    4,582,974

     

    Waystar

    Condensed Consolidated Statements of Cash Flows

    (in thousands)

    (unaudited)



















    Six months ended June 30, 





    2024



    2023

    Cash flows from operating activities













    Net loss



    $

    (43,617)



    $

    (21,433)

    Adjustments to reconcile net (loss) income to net cash provided by operating

         activities













    Depreciation and amortization





    88,450





    88,106

    Share-based compensation





    39,497





    4,298

    Provision for bad debt expense





    1,055





    1,097

    Loss on extinguishment of debt





    19,016





    —

    Deferred income taxes





    (42,377)





    (26,111)

    Amortization of debt discount and issuance costs





    2,646





    5,219

    Other





    (99)





    —

    Changes in:













    Accounts receivable





    (22,932)





    (392)

    Income tax refundable





    (4,371)





    4,351

    Prepaid expenses and other current assets





    (2,319)





    (2,808)

    Deferred costs





    (10,945)





    (7,548)

    Other long-term assets





    (442)





    (293)

    Accounts payable and accrued expenses





    4,392





    7,181

    Deferred revenue





    (910)





    (469)

    Operating lease right-of-use assets and lease liabilities





    (864)





    (789)

    Other long-term liabilities





    —





    42

    Net cash provided by operating activities





    26,180





    50,451

    Cash flows from investing activities













    Purchase of property and equipment and capitalization of internally developed

         software costs





    (12,428)





    (9,482)

    Net cash used in investing activities





    (12,428)





    (9,482)

    Cash flows from financing activities













    Change in aggregated funds liability





    2,327





    1,150

    Proceeds from equity offering, net of underwriting discounts





    914,288





    —

    Payments of third-party IPO issuance costs





    (1,982)





    —

    Repurchase of shares





    (844)





    (687)

    Proceeds from exercise of common stock





    (33)





    283

    Proceeds from issuances of debt, net of creditor fees





    535,209





    —

    Payments on debt





    (1,425,874)





    (8,991)

    Third-party fees paid in connection with issuance of new debt





    (1,410)





    —

    Finance lease liabilities paid





    (403)





    (411)

    Net cash provided by (used in) financing activities





    21,278





    (8,656)

    Increase in cash and cash equivalents during the period





    35,030





    32,313

    Cash and cash equivalents and restricted cash–beginning of period





    45,428





    72,636

    Cash and cash equivalents and restricted cash–end of period



    $

    80,458



    $

    104,949

    Supplemental disclosures of cash flow information













    Interest paid



    $

    82,264



    $

    94,648

    Cash taxes paid (refunds received), net





    26,141





    5,559

    Non-cash investing and financing activities













    Fixed asset purchases in accounts payable





    363





    420

    Unpaid third-party IPO issuance costs





    1,354





    —

    Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement













    Balance sheet













    Cash and cash equivalents





    68,375





    95,738

    Restricted cash





    12,083





    9,211

    Total





    80,458





    104,949

     

    Waystar



    Reconciliation of Adjusted EBITDA



    (in thousands)



    (unaudited)







    Three months ended

    June 30,







    2024





    2023



    Net Loss



    $

    (27,685)





    $

    (10,810)



    Interest expense





    50,541







    51,146



    Income tax benefit





    (14,611)







    (3,147)



    Depreciation and amortization





    44,276







    44,140



    Stock-based compensation expense





    36,969







    2,148



    Acquisition and integration costs





    206







    278



    Costs related to amended debt agreements





    2,368







    -



    IPO-related costs





    1,841







    3



    Adjusted EBITDA



    $

    93,905





    $

    83,758





















    Revenue





    234,543







    195,969



    Net loss margin





    (11.8)

    %





    (5.5)

    %

    Adjusted EBITDA margin





    40.0

    %





    42.7

    %

     

    Waystar



    Reconciliation of Non-GAAP Operating Expenses



    (in thousands)



    (unaudited)







    Three months ended

    June 30,







    2024





    2023



    Cost of revenue (exclusive of depreciation and amortization expenses)



    $

    80,451





    $

    60,500



    Less:

















    Stock-based compensation expense





    (1,739)







    (130)



    Acquisition and integration costs





    -







    -



    IPO-related costs





    (5)







    -



    Cost of revenue (exclusive of depreciation and amortization

    expenses), adjusted



    $

    78,707





    $

    60,370





















    Sales and marketing



    $

    45,715





    $

    31,413



    Less:

















    Stock-based compensation expense





    (8,892)







    (452)



    Acquisition and integration costs





    -







    (1)



    IPO-related costs





    (235)







    -



    Sales and marketing, adjusted



    $

    36,588





    $

    30,960





















    General and administrative



    $

    39,955





    $

    14,478



    Less:

















    Stock-based compensation expense





    (20,672)







    (1,264)



    Acquisition and integration costs





    (103)







    (152)



    Costs related to amended debt agreements





    (2,368)







    -



    IPO-related costs





    (1,592)







    (3)



    General and administrative, adjusted



    $

    15,220





    $

    13,059





















    Research and development



    $

    15,901





    $

    8,249



    Less:

















    Stock-based compensation expense





    (5,666)







    (302)



    Acquisition and integration costs





    (103)







    (125)



    IPO-related costs





    (9)







    -



    Research and development, adjusted



    $

    10,123





    $

    7,822





















    Income tax benefit



    $

    (14,611)





    $

    (3,147)



    Tax effect of adjustments





    8,691







    510



    Income tax benefit, adjusted



    $

    (5,920)





    $

    (2,637)



     

    Waystar



    Reconciliation of Non-GAAP Net Income



    (in thousands, except share and per share amounts)



    (unaudited)







    Three months ended

    June 30,







    2024





    2023



    Net Loss



    $

    (27,685)





    $

    (10,810)



    Stock-based compensation expense





    36,969







    2,148



    Acquisition and integration costs





    206







    278



    Costs related to amended debt agreements





    2,368







    -



    IPO-related costs





    1,841







    3



    Tax effect of adjustments





    (8,691)







    (510)



    Non-GAAP net income/(loss)



    $

    5,008





    $

    (8,891)





















    Non-GAAP net income/(loss) per share, basic





    0.04







    (0.07)



    Non-GAAP net income/(loss) per share, diluted





    0.04







    (0.07)





















    Weighted-average shares used in computing basic non-GAAP net income

    per share





    133,527,766







    121,676,273



    Weighted-average shares used in computing diluted non-GAAP net

    income per share





    137,294,656







    121,676,273



     

    Waystar



    Reconciliation of Unlevered Free Cash Flow



    (in thousands)



    (unaudited)







    Three months ended

    June 30,







    2024





    2023



    Net cash provided by operating activities



    $

    15,450





    $

    33,593



    Interest paid





    41,751







    47,910



    Purchase of property and equipment and capitalization of internally developed software costs





    (6,868)







    (4,712)



    Unlevered free cash flow



    $

    50,333





    $

    76,791



     

    Waystar



    Reconciliation of Net Debt



    (in thousands)



    (unaudited)







    June 30,

    2024





    June 30,

    2023



    First lien term loan facility outstanding debt, current



    $

    12,909





    $

    17,983



    First lien term loan facility outstanding debt, net of current portion





    1,277,991







    2,189,824



    Receivables facility outstanding debt





    70,000







    50,000



    Cash and cash equivalents





    (68,375)







    (95,738)



    Net debt



    $

    1,292,525





    $

    2,162,069





















    Trailing twelve months adjusted EBITDA



    $

    353,900





    $

    318,380





















    Adjusted gross leverage ratio





    3.8x







    7.1x



    Adjusted net leverage ratio





    3.7x







    6.8x



     

    Media Contact

    Kristin Lee 

    [email protected]

    Investor Contact

    Sandy Draper

    [email protected]

    502-238-9511 

    Cision View original content:https://www.prnewswire.com/news-releases/waystar-reports-second-quarter-2024-results-302217060.html

    SOURCE Waystar

    Get the next $WAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WAY

    DatePrice TargetRatingAnalyst
    3/14/2025$45.00Buy
    Truist
    2/11/2025$51.00Buy
    Jefferies
    11/22/2024$40.00Outperform → Strong Buy
    Raymond James
    7/2/2024$27.00Buy
    BofA Securities
    7/2/2024$24.00Overweight
    Barclays
    7/2/2024$27.00Buy
    Deutsche Bank
    7/2/2024$32.00Buy
    Goldman
    7/2/2024$24.00Overweight
    JP Morgan
    More analyst ratings

    $WAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Waystar Announces Proposed Public Offering of Common Stock

      LEHI, Utah and LOUISVILLE, Ky., May 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY) ("Waystar"), a provider of leading healthcare payments software, today announced a proposed underwritten public offering of 12,500,000 shares of its common stock being offered by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to 1,875,000 additional shares of common stock. Waystar is not selling any shares and will not receive any proceeds from the sale

      5/13/25 8:57:00 AM ET
      $WAY
      EDP Services
      Technology
    • Waystar Named Top Healthcare Payments Software Platform by MedTech Breakthrough

      Recognition underscores the differentiated value of Waystar's software platform in addressing nearly half a trillion dollars in administrative waste LEHI, Utah and LOUISVILLE, Ky., May 8, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced MedTech Breakthrough named it Best Overall Healthcare Payments Solutions Provider. This marks the fourth consecutive year that MedTech Breakthrough recognized Waystar, previously awarding the company the Healthcare Payments Innovation Award and Best New Technology Solution for Healthcare Payments.

      5/8/25 4:15:00 PM ET
      $WAY
      EDP Services
      Technology
    • Waystar to Present at Upcoming Investor Conferences

      LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins and Chief Financial Officer Steve Oreskovich will speak at two upcoming investor conferences. Oreskovich will present at the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025, at 8:40 a.m. PT. Hawkins will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, at 12 p.m. CT. Both presentations will stream live on Waystar's In

      4/30/25 4:15:00 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Financials

    Live finance-specific insights

    See more
    • Waystar Reports First Quarter 2025 Results

      Q1 revenue growth of 14% year-over-year Q1 net income of $29.3 million and non-GAAP net income of $58.7 million Q1 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the first quarter ended March 31, 2025. "Waystar sustained strong momentum in the first quarter of 2025, delivering net income margins exceeding 10%, adjusted EBITDA margins excee

      4/30/25 4:05:00 PM ET
      $WAY
      EDP Services
      Technology
    • Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025

      LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc

      4/7/25 4:30:00 PM ET
      $WAY
      EDP Services
      Technology
    • Waystar Reports Fourth Quarter and Fiscal Year 2024 Results

      Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please

      2/18/25 7:00:00 AM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Truist initiated coverage on Waystar Holding Corp. with a new price target

      Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00

      3/14/25 7:43:51 AM ET
      $WAY
      EDP Services
      Technology
    • Jefferies initiated coverage on Waystar Holding Corp. with a new price target

      Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00

      2/11/25 7:16:09 AM ET
      $WAY
      EDP Services
      Technology
    • Waystar Holding Corp. upgraded by Raymond James with a new price target

      Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00

      11/22/24 8:07:26 AM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Leadership Updates

    Live Leadership Updates

    See more
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care

    $WAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technology Officer Schremser Christopher L. exercised 8,623 shares at a strike of $4.14 and sold $346,352 worth of shares (8,623 units at $40.17) (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      5/12/25 4:52:18 PM ET
      $WAY
      EDP Services
      Technology
    • Chief Executive Officer Hawkins Matthew J. was granted 264,131 shares, increasing direct ownership by 53% to 764,131 units (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      5/12/25 8:37:21 AM ET
      $WAY
      EDP Services
      Technology
    • Chief Technology Officer Schremser Christopher L. exercised 8,623 shares at a strike of $4.14 and sold $313,546 worth of shares (8,623 units at $36.36) (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      4/14/25 4:31:13 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairperson Driscoll John Patrick was granted 8,695 shares and bought $129,000 worth of shares (6,000 units at $21.50), increasing direct ownership by 21% to 85,623 units (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      6/12/24 4:32:09 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    SEC Filings

    See more
    • SEC Form S-1 filed by Waystar Holding Corp.

      S-1 - Waystar Holding Corp. (0001990354) (Filer)

      5/13/25 8:50:31 AM ET
      $WAY
      EDP Services
      Technology
    • SEC Form DEFA14A filed by Waystar Holding Corp.

      DEFA14A - Waystar Holding Corp. (0001990354) (Filer)

      5/12/25 7:05:52 AM ET
      $WAY
      EDP Services
      Technology
    • Waystar Holding Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Waystar Holding Corp. (0001990354) (Filer)

      5/12/25 7:05:28 AM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Waystar Holding Corp.

      SC 13G - Waystar Holding Corp. (0001990354) (Subject)

      11/14/24 5:30:28 PM ET
      $WAY
      EDP Services
      Technology
    • SEC Form SC 13G filed by Waystar Holding Corp.

      SC 13G - Waystar Holding Corp. (0001990354) (Subject)

      11/14/24 6:00:14 AM ET
      $WAY
      EDP Services
      Technology
    • SEC Form SC 13G filed by Waystar Holding Corp.

      SC 13G - Waystar Holding Corp. (0001990354) (Subject)

      11/8/24 4:30:50 PM ET
      $WAY
      EDP Services
      Technology